Successful Treatment of Extensively Drug-Resistant Acinetobacter baumannii Peritoneal Dialysis Peritonitis with Intraperitoneal Polymyxin B and Ampicillin-Sulbactam

@article{Fitzpatrick2012SuccessfulTO,
  title={Successful Treatment of Extensively Drug-Resistant Acinetobacter baumannii Peritoneal Dialysis Peritonitis with Intraperitoneal Polymyxin B and Ampicillin-Sulbactam},
  author={M. Fitzpatrick and John S. Esterly and M. Postelnick and S. Sutton},
  journal={Annals of Pharmacotherapy},
  year={2012},
  volume={46},
  pages={e17 - e17}
}
  • M. Fitzpatrick, John S. Esterly, +1 author S. Sutton
  • Published 2012
  • Medicine
  • Annals of Pharmacotherapy
  • OBJECTIVE: To describe a case of extensively drug-resistant (XDR) Acinetobacter baumannii peritoneal dialysis (PD)–associated peritonitis successfully treated with combination antibiotics, including intraperitoneal polymyxin B, with retention of the catheter. CASE SUMMARY: A 54-year-old woman with end-stage renal disease receiving chronic PD and recent antibiotic and hospital exposure presented with abdominal pain, nausea, and vomiting. She was found to have XDR A. baumannii PD peritonitis… CONTINUE READING
    7 Citations
    Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis
    • 9
    • PDF
    Clinical Use of Polymyxin B.
    • 4
    ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment
    • 422
    • PDF
    Multiresistente gramnegative Erreger

    References

    SHOWING 1-10 OF 24 REFERENCES
    Acinetobacter Peritoneal Dialysis Peritonitis: Description and Relation to the spice Family of Organisms
    • 11
    Acinetobacter peritonitis during chronic peritoneal dialysis.
    • 27
    Ampicillin and Sulbactam Pharmacokinetics and Pharmacodynamics in Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • 16
    Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
    • Lisa L. Maragakis, T. Perl
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2008
    • 850
    • PDF